24.21
price up icon0.88%   0.21
after-market Handel nachbörslich: 24.40 0.19 +0.78%
loading

Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten

pulisher
Sep 26, 2025

13,670 Shares in Tonix Pharmaceuticals Holding Corp. $TNXP Purchased by Rhumbline Advisers - MarketBeat

Sep 26, 2025
pulisher
Sep 24, 2025

Tonix advances TNX-102 SL for depression after positive FDA meeting boosts development path - Proactive financial news

Sep 24, 2025
pulisher
Sep 24, 2025

What is Zacks Small Cap's Estimate for TNXP FY2025 Earnings? - MarketBeat

Sep 24, 2025
pulisher
Sep 23, 2025

Tonix Pharma Licenses Rights to Lyme Disease Antibody - MSN

Sep 23, 2025
pulisher
Sep 22, 2025

Daily Brief Health Care: Shandong Weigao Blood Purification Products, TYK Medicines, Butong Group, Alteogen Inc, SBC Medical Group Holdings , Achieve Life Sciences , Tonix Pharmaceuticals Holding and more - Smartkarma

Sep 22, 2025
pulisher
Sep 22, 2025

Tonix gains global rights to TNX-4800, developing one-dose seasonal protection for Lyme disease - Proactive financial news

Sep 22, 2025
pulisher
Sep 22, 2025

TNXP: Tonmya™ Approved by FDA… - Zacks Small Cap Research

Sep 22, 2025
pulisher
Sep 21, 2025

Tonix Pharmaceuticals Holding Corp.(NasdaqCM: TNXP) added to S&P Global BMI Index - MarketScreener

Sep 21, 2025
pulisher
Sep 18, 2025

Tonix plans IND filing for depression treatment after FDA meeting By Investing.com - Investing.com Nigeria

Sep 18, 2025
pulisher
Sep 18, 2025

Analyst Downgrade: Is now the right time to enter Tonix Pharmaceuticals Holding CorpWeekly Risk Report & Low Drawdown Investment Strategies - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Tonix plans IND filing for depression treatment after FDA meeting - Investing.com India

Sep 18, 2025
pulisher
Sep 18, 2025

Tonix Pharma Completes FDA Meeting for TNX-102 SL - TipRanks

Sep 18, 2025
pulisher
Sep 18, 2025

Fed Watch: Can LeddarTech Holdings Inc Equity Warrant navigate macro headwindsQuarterly Risk Review & Low Risk Entry Point Tips - خودرو بانک

Sep 18, 2025
pulisher
Sep 18, 2025

Tonix Pharmaceuticals (TNXP) Advances Toward New Depression Trea - GuruFocus

Sep 18, 2025
pulisher
Sep 18, 2025

Tonix Pharmaceuticals Announces Positive Pre-IND Meeting with FDA for TNX-102 SL for the Treatment of Major Depressive Disorder - The Manila Times

Sep 18, 2025
pulisher
Sep 18, 2025

Tonix Pharmaceuticals Announces Plans for IND Filing of TNX-102 SL for Major Depressive Disorder Following Positive FDA Pre-IND Meeting - Quiver Quantitative

Sep 18, 2025
pulisher
Sep 18, 2025

Tonix reports positive pre-IND FDA meeting for TNX-102 SL in major depressive disorder treatment - MarketScreener

Sep 18, 2025
pulisher
Sep 18, 2025

Tonix Reports Positive Pre-IND FDA Meeting for TNX-102 SL in Major Depressive Disorder Treatment - TradingView

Sep 18, 2025
pulisher
Sep 18, 2025

Tonix Pharmaceuticals Announces Positive Pre-IND Meeting - GlobeNewswire

Sep 18, 2025
pulisher
Sep 18, 2025

FDA-Approved Fibromyalgia Drug TNX-102 SL Shows Promise for Major Depression Treatment - Stock Titan

Sep 18, 2025
pulisher
Sep 17, 2025

Revolutionary 1-shot Lyme disease prevention approved - Rolling Out

Sep 17, 2025
pulisher
Sep 17, 2025

Tonix Pharmaceuticals (TNXP) Gains on Lyme Disease Treatment Lic - GuruFocus

Sep 17, 2025
pulisher
Sep 17, 2025

Tonix licenses monoclonal antibody for Lyme disease prevention By Investing.com - Investing.com South Africa

Sep 17, 2025
pulisher
Sep 17, 2025

Tonix Pharmaceuticals gets global rights to Lyme disease treatment - Seeking Alpha

Sep 17, 2025
pulisher
Sep 17, 2025

Tonix Pharmaceuticals (TNXP) Secures Rights to Potential Lyme Di - GuruFocus

Sep 17, 2025
pulisher
Sep 17, 2025

Tonix Pharmaceuticals Secures Rights to Lyme Disease Prevention Candidate - MarketScreener

Sep 17, 2025
pulisher
Sep 17, 2025

Tonix Pharmaceuticals announces in-licensing of worldwide rights to TNX-4800 - TipRanks

Sep 17, 2025
pulisher
Sep 17, 2025

Tonix licenses monoclonal antibody for Lyme disease prevention - Investing.com

Sep 17, 2025
pulisher
Sep 17, 2025

Tonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800) - The Manila Times

Sep 17, 2025
pulisher
Sep 17, 2025

Tonix Pharmaceuticals In-Licenses TNX-4800 for Lyme Disease Prevention Following Positive Phase 1 Study Results - Quiver Quantitative

Sep 17, 2025
pulisher
Sep 17, 2025

Tonix Pharmaceuticals Announces In-licensing Phase - GlobeNewswire

Sep 17, 2025
pulisher
Sep 17, 2025

70M Americans Could Benefit: Tonix's New Once-Yearly Antibody Shows Promise in Preventing Lyme Disease - Stock Titan

Sep 17, 2025
pulisher
Sep 17, 2025

UMass Chan licenses monoclonal antibody for seasonal prevention of Lyme disease to Tonix Pharmaceuticals - UMass Chan Medical School

Sep 17, 2025
pulisher
Sep 16, 2025

Is Tonix Pharmaceuticals Holding Corp stock risky to hold nowLayoff News & Safe Capital Investment Plans - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Pattern recognition hints at Tonix Pharmaceuticals Holding Corp. upsideJuly 2025 EndofMonth & Intraday High Probability Alerts - newser.com

Sep 16, 2025
pulisher
Sep 16, 2025

Investment Recap: Will Tonix Pharmaceuticals Holding Corp announce a stock splitPortfolio Value Summary & Verified Entry Point Detection - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Aug Fed Impact: What are analysts price targets for Tonix Pharmaceuticals Holding CorpMarket Performance Recap & High Conviction Trade Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

What’s the RSI of Tonix Pharmaceuticals Holding Corp. stockMarket Risk Report & Momentum Based Trading Ideas - خودرو بانک

Sep 16, 2025
pulisher
Sep 16, 2025

Sell Signal: Is Tonix Pharmaceuticals Holding Corp. exposed to currency risksWeekly Market Outlook & Accurate Trade Setup Notifications - khodrobank.com

Sep 16, 2025
pulisher
Sep 16, 2025

Bull Bear: Does Tonix Pharmaceuticals Holding Corp offer margin of safetyRisk Management & Technical Confirmation Trade Alerts - خودرو بانک

Sep 16, 2025
pulisher
Sep 15, 2025

Published on: 2025-09-15 21:26:59 - خودرو بانک

Sep 15, 2025
pulisher
Sep 15, 2025

Aug EndMonth: Will Tonix Pharmaceuticals Holding Corp stock benefit from M ADividend Hike & Stepwise Entry/Exit Trade Alerts - خودرو بانک

Sep 15, 2025
pulisher
Sep 12, 2025

Tonix showcases Phase 3 data for FDA-approved Tonmya at PAINWEEK 2025, eyes launch next quarter - Proactive financial news

Sep 12, 2025
pulisher
Sep 10, 2025

Tonix Pharmaceuticals : September 2025 Investor Deck - MarketScreener

Sep 10, 2025
pulisher
Sep 08, 2025

Published on: 2025-09-08 16:12:23 - beatles.ru

Sep 08, 2025
pulisher
Sep 08, 2025

Tonix Pharmaceuticals Presents Clinical Data on Tonmya™ for the - GuruFocus

Sep 08, 2025
pulisher
Sep 08, 2025

Tonix Pharmaceuticals Presents Clinical Data on Tonmya™ for the Treatment of Fibromyalgia at PAINWEEK 2025 - Yahoo Finance

Sep 08, 2025
pulisher
Sep 07, 2025

Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Passes Above Two Hundred Day Moving AverageHere's Why - MarketBeat

Sep 07, 2025
pulisher
Sep 06, 2025

Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week - MSN

Sep 06, 2025
pulisher
Sep 06, 2025

Combining machine learning predictions for Tonix Pharmaceuticals Holding Corp.Wall Street Watch & Safe Capital Growth Tips - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Is Tonix Pharmaceuticals Holding Corp. stock entering bullish territoryJuly 2025 Review & AI Optimized Trade Strategies - Newser

Sep 06, 2025
pulisher
Sep 06, 2025

Will Tonix Pharmaceuticals Holding Corp. outperform its industry peersNew Guidance & Technical Pattern Based Buy Signals - خودرو بانک

Sep 06, 2025
pulisher
Sep 05, 2025

What technical models suggest about Tonix Pharmaceuticals Holding Corp.’s comebackWeekly Trade Review & Reliable Trade Execution Plans - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Why is Tonix Pharmaceuticals Holding Corp. stock going downStop Loss & AI Based Buy/Sell Signal Reports - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Using data models to predict Tonix Pharmaceuticals Holding Corp. stock movementSell Signal & Low Drawdown Trading Techniques - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

What’s the MACD signal for Tonix Pharmaceuticals Holding Corp.2025 Technical Patterns & Smart Swing Trading Alerts - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Heatmap analysis for Tonix Pharmaceuticals Holding Corp. and competitorsWeekly Volume Report & Real-Time Market Sentiment Reports - Newser

Sep 05, 2025
$20.95
price up icon 3.41%
$82.70
price up icon 1.27%
$29.07
price up icon 0.80%
$98.08
price up icon 0.00%
$137.03
price up icon 1.06%
biotechnology ONC
$326.06
price down icon 0.81%
Kapitalisierung:     |  Volumen (24h):